Improved Adherence and Less Toxicity With Rifampin vs Isoniazid for Treatment of Latent Tuberculosis

Authors:
  • FSFrangiscos Sifakis
    Frangiscos Sifakis
  • RORuben Montes de Oca
    Ruben Montes de Oca
  • WCWendy A. Cronin
    Wendy A. Cronin
  • MDMeg C. Doherty
    Meg C. Doherty
  • LFLynn Federline
    Lynn Federline
  • SBSarah Bur
    Sarah Bur
  • TWThomas Walsh
    Thomas Walsh
  • WKWalter Karney
    Walter Karney
  • JMJames Milman
    James Milman
  • NBNancy Baruch
    Nancy Baruch
  • AAAkintoye Adelakun
    Akintoye Adelakun

Abstract
Research from JAMA Internal Medicine — Improved Adherence and Less Toxicity With Rifampin vs Isoniazid for Treatment of Latent Tuberculosis — A Retrospective Study

This publication has 11 references indexed in Scilit: